Kopferschmitt-Kubler M-C, Popin E, Pauli G
Département de pneumologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Rev Mal Respir. 2008 Oct;25(8):999-1012. doi: 10.1016/s0761-8425(08)74416-4.
Occupational asthma (OA), with a latency period induced by multiple exposures, is characterized by immunological sensitization to the responsible agent, based on both an IgE mediated mechanisms and non specific bronchial hyper responsiveness.
In the diagnosis of OA, the medical history is obviously the starting-point. Onset of respiratory symptoms at work and resolution on vacation are indications of the diagnosis. After analysis of several publications, this element appears to have the best level of proof (grade 2+) according to the criteria of evidence-based medicine. A visit of the workplace, with the cooperation of the industrial physician, is essential to characterize the nature of the exposure. Positive immunological tests (skin tests and/or specific IgE) associated with objective criteria of symptoms related to work (modification of PEFR, lung function and/or nonspecific bronchial hyper responsiveness) will confirm the aetiological diagnosis of OA. Specific bronchial provocation tests performed in the laboratory allow the identification of new agents involved in OA and are necessary when other investigations are discordant or unavailable. OA needs a stepwise approach including induced sputum eosinophilic counts and measurements of exhaled nitric oxide.
OA requires removal from the workplace because persistence of exposure to respiratory sensitisers may lead to an increase and prolongation of asthma symptoms. However, removal from the workplace can have tremendous professional, financial and social consequences, and sometimes a compromise must be found with reduction of exposure by various methods combined with adequate treatment. The pharmacological treatment of patients with OA should be the same as for patients with non OA, the use of bronchodilators and corticoids depending on the severity of asthma. Concerning the medico-legal aspects, OA can be recognised as an occupational disease. In France OA is included in several tables of work-related diseases.
职业性哮喘(OA)由多次接触引发潜伏期,其特征是基于IgE介导机制和非特异性支气管高反应性,对致病因子产生免疫致敏。
在OA的诊断中,病史显然是起点。工作时出现呼吸道症状而休假时症状缓解是诊断的指征。分析多篇文献后,根据循证医学标准,这一要素似乎具有最佳的证据水平(2+级)。在工业医师的协作下对工作场所进行走访,对于明确接触的性质至关重要。与工作相关症状的客观标准(呼气峰流速、肺功能和/或非特异性支气管高反应性改变)相关的阳性免疫检测(皮肤试验和/或特异性IgE)将证实OA的病因诊断。在实验室进行的特异性支气管激发试验可识别参与OA的新致病因子,当其他检查结果不一致或无法进行时,该试验是必要的。OA需要采用逐步的方法,包括诱导痰嗜酸性粒细胞计数和呼出一氧化氮测量。
OA的管理:OA患者需要调离工作场所,因为持续接触呼吸道致敏剂可能导致哮喘症状加重和持续时间延长。然而,调离工作场所可能会带来巨大的职业、经济和社会后果,有时必须通过多种方法减少接触并结合适当治疗来找到折中的办法。OA患者的药物治疗应与非OA患者相同,根据哮喘的严重程度使用支气管扩张剂和皮质激素。关于医疗法律方面,OA可被认定为职业病。在法国,OA被列入多个与工作相关疾病的表格中。